Hospital-acquired pneumonia (HAP) is a significant infection prevention concern, leading to high patient mortality, increased health care costs, and ICU usage. Oral hygiene is an effective preventive measure.
Glowing monitors in the intensive care department. Night shift at ICU, patient in a critical state.
(Adobe Stock 252813850 @ Kirl Lis)
High Cost of Pneumonia
Hospital-acquired pneumonia (HAP) not only threatens patient safety but also exerts a significant financial burden on healthcare systems. According to the CDC's most recent point prevalence survey, HAP is the number one healthcare-acquired infection (HAI), accounting for one in every 4 infections.1 In addition to being highly prevalent, HAP impacts resource utilization, quality metrics, value-based purchasing (VBP) initiatives, and patient satisfaction.
HAP is a confirmed pneumonia diagnosis that occurs 48 hours after hospitalization and is not present on admission.2 Ventilator-associated pneumonia (VAP) is associated with the use of an artificial airway, although most health care-acquired pneumonia (HAP) cases are not linked to a ventilator. Nonventilator-associated HAP (NV-HAP) is now a larger concern (Graph 1).
Table 1. Impact of Hospital-Acquired Pneumonia21-22
(Credit: Author)
VAP and NV-HAP are frequent and serious preventable conditions that impact patients and health care systems. High mortality, increased length of hospital and intensive care unit (ICU) stays, increased utilization of ICUs, and frequent hospital readmission contribute to increased costs to patients, families, and institutions. (Table 1). In a retrospective case-control study of Medicare patients hospitalized in 2019, those with HAP were almost 3 times more likely to die within 90 days compared to matched controls without HAP, and those with HAP spent an extra week in the hospital, increasing the cost of care by 24%.3
Oral Hygiene as Prevention
While medical interventions are essential in managing HAP, oral hygiene's prevention role is often overlooked and is one of the most frequently missed elements of care.4 However, recent research underscores the hidden benefits of oral hygiene practices in averting VAP and NV-HAP, improving overall patient outcomes, including substantial cost savings and enhanced value-based care benefits.
Graph 1. Distribution of VAP and NV-HAP1
(Credit: Author)
Why use oral hygiene to prevent pneumonia? Oral hygiene is the only intervention that addresses source control by reducing the pathogens that lead to pneumonia. During hospitalization, the healthy oral microbiome is disrupted, allowing the growth and replication of pathogens that can cause infection.5 These pathogens are frequently microaspirated into the airway and can lead to pneumonia.6
Comprehensive oral hygiene breaks this chain of infection and combats pneumonia-causing pathogens before they can enter the lungs. Daily oral care is recognized as an Essential Practice in the pneumonia prevention guidelines updated in 2022.7 In a recent systematic review, daily toothbrushing was the most effective aspect of oral hygiene and was associated with a reduction in HAP, mortality, and length of stay.8
Multiple studies have shown a correlation between consistent oral hygiene and a reduction in HAP. One large urban hospital implemented a comprehensive oral hygiene program for all adult patients, including high-risk critical care and oncology. The 12-month study successfully increased oral care quality and frequency in all units and reduced NV-HAP by 39%, saving an estimated 8 lives, avoiding 500 hospital days, and saving $1.72 million in costs.9 As the implementation continued into another 12 months, oral care was incorporated into presurgical routines. Over 2 years, 164 NV-HAP cases were avoided, with an estimated 31 lives saved and $6.2 million in cost-avoidance.10
Table 2. Impact of HAP on Key Quality Metrics
(Credit: Author)
Cost Savings and Resource Utilization
Preventing HAP through an oral hygiene intervention yields tangible cost savings for healthcare institutions by sparing precious resources. HAP has a direct impact on resources such as ICU and hospital days and antibiotic use. HAP extends the length of time in the hospital. Patients must stay in the hospital for an additional 6.6 days for NV-HAP and 28 days for VAP.11,12
HAP drives ICU utilization from nonventilated ICU patients as well as patients on medical units. In a US 21-hospital study by Baker and Quinn (2018), 46% of patients with NV-HAP required critical care, and 27% were transferred to the ICU from medical and surgical units.13
HAP requires the use of antibiotics at a time when stewardship is imperative. An astounding 50-70% of antibiotic usage in ICUs is prescribed to treat HAP.14 A large hospital system demonstrated a reduction in broad-spectrum antibiotic use when lowering NV-HAP.15 By providing an oral care intervention and preventing HAP, hospitals can decrease the length of patient hospitalization, minimize the need for intensive care services, and curtail antibiotic usage, all of which contribute to freeing up resources and lower healthcare expenditures.
Quality Metrics and Value-Based Purchasing
In addition to sparing resources, preventing HAP through oral hygiene aligns with quality metrics and VBP initiatives in healthcare. VBP programs incentivize hospitals to deliver high-quality, cost-effective care by linking reimbursement to performance on various quality measures, including infection rates and patient outcomes.16
HAP contributes to quality measures that impact financial reimbursement, hospital accreditation, and public reputation (See Table 2). One important metric is SEP-1, a VBP measure that affects CMS reimbursement.16 SEP-1 is a 3-hour all-or-none bundle focused on early recognition and treatment. SEP-1 compliance has been challenging, with a rate of less than 50% in US hospitals.17
HAP is the most common site of infection for hospital-acquired sepsis and the leading cause of death among hospitalized patients.17 Focusing efforts on preventing HAP by providing oral hygiene can reduce the number of sepsis cases in the hospital and relieve the burden of adherence to time-sensitive treatment.
Stay ahead of sepsis by Infection Control Today
Enhanced Patient Satisfaction
Improving oral hygiene brings financial benefits and enhances patient satisfaction, which is a crucial aspect of healthcare.18 When patients are hospitalized, they expect proper oral hygiene, and research indicates that they notice when it is not provided.19 To improve the patient's experience and sense of control, it is advisable to provide education about the importance of oral hygiene during hospital stays and assist with daily oral hygiene tasks.20 Engaging patients in daily oral hygiene offers an opportunity to improve a key quality metric: patient satisfaction. (Table 2)
Conclusion
The benefits of preventing hospital-acquired pneumonia through oral hygiene go beyond cost savings. Prioritizing a standard oral hygiene program not only prevents the risk of HAP but also affects resource utilization, quality metrics, VBP initiatives, and patient satisfaction. Integrating oral hygiene protocols into routine infection prevention practices is essential for the well-being of hospitalized individuals and healthcare organizations.
References:
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
2 Commerce Drive
Cranbury, NJ 08512